OverviewSuggest Edit

    Revalesio is a company developing treatments for neurological disorders. It utilizes fluid modification via turbulent Taylor-Couette-Poiseuille (TCP) flow to improve cellular bioenergetics. Revalesio drug candidate targets amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).

    Latest Updates

    Employees (est.) (Mar 2020)17

    Revalesio Financials and Metrics

    Summary Metrics

    Founding Date


    Revalesio latest funding size

    $14 m
    Show all financial metrics

    Revalesio Online and Social Media Presence

    Embed Graph

    Revalesio Frequently Asked Questions

    • When was Revalesio founded?

      Revalesio was founded in 2006.

    • How many employees does Revalesio have?

      Revalesio has 17 employees.

    • Who are Revalesio competitors?

      Competitors of Revalesio include Aptuit, Fortress Biotech and Kezar Life Sciences.